| Literature DB >> 27229174 |
Hong-Chang Tian1,2,3, Jing-Quan Liu1,2,3, Xiao-Yang Kang1,2,3, Long-Jun Tang1,2,3, Ming-Hao Wang1,2,3, Bo-Wen Ji1,2,3, Bin Yang1,2,3, Xiao-Lin Wang1,2,3, Xiang Chen1,2,3, Chun-Sheng Yang1,2,3.
Abstract
Implantable biomedical microdevices enable the restoration of body function and improvement of health condition. As the interface between artificial machines and natural tissue, various kinds of microelectrodes with high density and tiny size were developed to undertake precise and complex medical tasks through electrical stimulation and electrophysiological recording. However, if only the electrical interaction existed between electrodes and muscle or nerve tissue without nutrition factor delivery, it would eventually lead to a significant symptom of denervation-induced skeletal muscle atrophy. In this paper, we developed a novel flexible tubular microelectrode integrated with fluidic drug delivery channel for dynamic tissue implant. First, the whole microelectrode was made of biocompatible polymers, which could avoid the drawbacks of the stiff microelectrodes that are easy to be broken and damage tissue. Moreover, the microelectrode sites were circumferentially distributed on the surface of polymer microtube in three dimensions, which would be beneficial to the spatial selectivity. Finally, the in vivo results confirmed that our implantable tubular microelectrodes were suitable for dynamic electrophysiological recording and simultaneous fluidic drug delivery, and the electrode performance was further enhanced by the conducting polymer modification.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27229174 PMCID: PMC4882553 DOI: 10.1038/srep26910
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Schematic illustration of the flexible tubular microelectrode and the corresponding fabrication processes.
(a) The construction and multi-function illustration of the flexible tubular microelectrode, comprising multi-channel electrode sites for electrical stimulation/recording and fluidic channel for drug delivery. (b) The fabrication process of the tubular microelectrode, mainly including: fabrication of parylene thin film microelectrode, wrapping and gluing on the polyimide capillary, and electrochemical deposition of conducting polymer.
Figure 2(a,b) Prototype of the overall relaxed and bended tubular microelectrode, respectively. (c,d) The electrode sites of the thin film microelectrode and the tubular microelectrode, respectively. The golden and black sites were bare gold and PEDOT/PSS modified electrode sites, respectively. (e,f) Enlarged view of single electrode site morphology of bare gold and PEDOT/PSS modified electrode sites, respectively. (g,h) finite element simulation results of current streamline distribution for small and large reference electrode configuration, respectively. (i) Immunofluorescent image of PC-12 cells cultured for 7 days with the addition of neural growth factor (NGF).
Figure 3(a,b) Impedance plot and phase plot of electrochemical impedance spectra (EIS) of the tubular microelectrodes with and without PEDOT/PSS modification, respectively. Msd and Cal in the figure legend referred to the measured result and fitting result by equivalent circuit, respectively. The insertion indicated the equivalent circuit for EIS fitting. (c) Cyclic voltammograms (CV) of the tubular microelectrodes with and without PEDOT/PSS modification. The arrows indicated the cyclic scanning direction. (d) Strain-stress test results of the tubular microelectrode (red) and polyimide capillary (green). The insertion referred to the broken moment on the test equipment. (e) Remain of impedance (red) and CSC (green) of the tubular microelectrodes after repeatedly bending to the angle of 30°, 60° and 90° for 50, 100, 150 and 200 times, separately. (f) Flow resistance tested (green) and calculated (blue) results. The insertion referred to the multi-channel fluidic test equipment.
The numerical fitting results of equivalent circuit components of bare gold electrodes and PEDOT/PSS coated electrodes.
| Items | χ2 | ||||||
|---|---|---|---|---|---|---|---|
| Bare gold electrode | 1.375 × 10−8 | 0.8129 | 1.059 × 1016 | – | – | – | 1.435 × 10−2 |
| PEDOT/PSS thin film electrode | 7.46 × 10−5 | 0.5062 | 587.6 | 7.104 × 10−7 | 1.256 × 10−3 | 6.086 × 10−6 | 2.871 × 10−4 |
| PEDOT/PSS thick film electrode | 2.045 × 10−4 | 0.1431 | 1.204 × 104 | 1.066 × 10−6 | 2.373 × 10−3 | 1.814 × 10−5 | 1.886 × 10−3 |
Figure 4The electrophysiological experiment configuration and results in vivo.
(a,b) Illustrative and actual configuration of the electrophysiological experiment, respectively. (c) X-ray image of the rat hind leg, in which the yellow dash line indicated the location of implanted tubular microelectrodes in gastrocnemius (GA) and tibialis anterior (TA). (d) EMG signals recorded by PEDOT/PSS modified electrode in GA (CH1), bare gold electrode in GA (CH2), PEDOT/PSS modified electrode in TA (CH3) and bare gold electrode in TA (CH4). The waveforms on the left and right referred to the EMG signal recording before and after lidocaine injection, respectively. (e,f) Frequency spectrum analysis of EMG signals before and after lidocaine injection, respectively.